Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | BLM | P54132 | 2/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TAS2R38 | P59533 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 3/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
| ▸ | THPO | P40225 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CA5A | P35218 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5172269 | 1.00 | CRBN (0.48) | CRBNLMNABLMPMP22ALOX15 | |
| SCHEMBL4378123 | 0.79 | CRBN (0.39) | CRBNTAS2R38KDM4EATMTSHR | |
| SCHEMBL3506421 | 0.79 | CRBN (0.39) | CRBNTAS2R38KDM4EATMTSHR | |
| SCHEMBL3506422 | 0.79 | CRBN (0.39) | CRBNTAS2R38KDM4EATMTSHR | |
| SCHEMBL25063306 | 0.76 | — | — | |
| SCHEMBL27897254 | 0.76 | — | — | |
| SCHEMBL21226771 | 0.73 | CRBN (0.37) | CRBN | |
| Acetic Acid SCHEMBL28316382 | 0.72 | CRBN (0.65) | CRBNLMNABLMPMP22ALOX15 | |
| SCHEMBL12315631 | 0.71 | TGFBR1 (0.35) | KDM4E | |
| SCHEMBL337169 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101443664-A | Mass tags for quantitative analyses | APPLERA CORP (US) | 2009-05-27 | — | — | CN | disclosed |
| EP-1776588-A1 | MASS TAGS FOR QUANTITATIVE ANALYSES | Applera Corporation (US) | 2007-04-25 | — | — | EP | disclosed |
| US-20060172319-A1 | Mass tags for quantitative analyses | APPLERA CORPORATION (US) | 2006-08-03 | — | — | US | disclosed |
| WO-2006017208-A1 | MASS TAGS FOR QUANTITATIVE ANALYSES | APPLERA CORPORATION (US) | 2006-02-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060172319-A1 | Mass tags for quantitative analyses | SRMS, PTMS, TMT1A | CRBN 392/4885LMNA 863/4885BLM 1254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.